Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically meaningful improvements of protein in urine observed as early as two weeks, with ...
A new Northwestern Medicine study has uncovered how a key immunoregulatory receptor plays an unexpected dual role in ...
Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically meaningful improvements of protein in urine observed as early as two weeks, with s ...
India has a unique opportunity to lead in non-animal drug testing, enhancing innovation and efficiency in pharmaceutical ...
Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people ...
The Santa Marta Conference was more than a meeting on transitioning away from fossil fuels, what does the initiative reveal ...
New research in Energy Research & Social Science reveals how stakeholder power dynamics in Barbados shape — and slow — the ...
The impossible RCP8.5 has been used as a reference case in more than 70 peer-reviewed articles despite its official ...
Summary: Researchers compiled emerging evidence to prove that astrocytes, traditionally dismissed as passive, structural ...
New research has uncovered a hidden pathway that allows COVID-19 to infect the immune system and trigger damaging ...
New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...
NMIMS launches Horizon initiative to embed AI skills in student curriculum, enhancing career readiness for an AI-driven economy.